» Articles » PMID: 24518855

The Diagnosis and Classification of Undifferentiated Connective Tissue Diseases

Overview
Journal J Autoimmun
Date 2014 Feb 13
PMID 24518855
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The term undifferentiated connective tissue disease (UCTD) refers to unclassifiable systemic autoimmune diseases which share clinical and serological manifestations with definite connective tissue diseases (CTDs) but not fulfilling any of the existing classification criteria. In this review we will go through the more recent evidence on UCTD and we will discuss in what extent the availability of new criteria for the CTDs could interfere with the "UCTD concept". The development of criteria able to identify early phases of defined CTD, may help in the differentiation of stable UCTD form their early stages and may offer a valuable guide to the treating physician to set up appropriate follow up schedules as well as therapeutic protocols. This simplified subset of CTD could offer a model to study clinic pathological correlations as well as the role of possible environmental factors in the development of autoimmunity.

Citing Articles

Risk of mycobacterial infections in a cohort of silicosis patients with autoimmune rheumatic diseases.

Mizutani R, Santos U, Sales R, Yuki E, Lombardi E, Roio L J Bras Pneumol. 2024; 50(5):e20240265.

PMID: 39661841 PMC: 11601091. DOI: 10.36416/1806-3756/e20240265.


ANA-associated arthritis: clinical and biomarker characterization of a population for basket trials.

Arnold J, Carter L, Md Yusof M, Dutton K, Wigston Z, Dass S Rheumatology (Oxford). 2024; 63(11):3135-3145.

PMID: 39087598 PMC: 11534109. DOI: 10.1093/rheumatology/keae269.


The relationship between neuromyelitis optica spectrum disorder and autoimmune diseases.

Lin J, Xue B, Li J, Xie D, Weng Y, Zhang X Front Immunol. 2024; 15:1406409.

PMID: 38994358 PMC: 11236685. DOI: 10.3389/fimmu.2024.1406409.


Disease evolution and organ damage accrual in patients with stable UCTD: a long-term monocentric inception cohort.

Tani C, Trentin F, Parma A, Zucchi D, Cardelli C, Stagnaro C RMD Open. 2024; 10(2).

PMID: 38670557 PMC: 11057319. DOI: 10.1136/rmdopen-2023-003967.


Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia.

An Q, Ma R, Yuan D, Huang J, Luo J, Wang Y Clin Rheumatol. 2024; 43(5):1491-1501.

PMID: 38494557 DOI: 10.1007/s10067-024-06937-0.